Table 3 Relationships between possible predictors of the effective reproductive number of the most predominant variants of COVID-19.

From: Genomic epidemiology of SARS-CoV-2 variants during the first two years of the pandemic in Colombia

Lineage

Mobility

Stringency index

Vaccinated

Mask use

Cases

B.1.1

0.03 (0.05)

−0.003 (0.39)

NA

−0.01 (0.64)

−0.01 (0.92)

B.1.111

−0.01 (0.63)

0.4 (1.1e−08)*

NA

0.53 (3.22e−12)*

−0.008 (0.49)

B.1.1.348

0.01 (0.15)

−0.01 (0.70)

NA

0.2 (8.88e−05)*

0.28 (1.98e−05)*

B.1.420

0.20 (0.04)*

−0.02 (0.44)

NA

−0.04 (0.56)

0.53 (0.0007)*

B.1.617 (Delta)

0.54 (<2.2e−11)*

0.40 (<3.82e−08)*

0.36 (<2.62e−05)*

0.47 (<1.67e−09)*

−0.01 (0.91)

P.1 (Gamma)

0.51 (8.17e−09)*

0.50 (1.33e−08)*

0.57 (2.44e−09)*

0.50 (1.5e−08)*

0.09 (0.02)*

B.1.1.7 (Alpha)

−0.001 (0.33)

−0.01 (0.51)

−0.02 (0.54)

0.25 (0.002)*

0.15 (0.01)*

B.1.621 (Mu)

0.49 (2.21e−08)*

0.25 (0.0001)*

0.49 (1.80e−08)*

0.46 (8.92e−08)*

0.01 (0.21)

C.37 (Lambda)

−0.04 (0.84)

0.03 (0.21)

0.62 (0.0002)*

0.15 (0.03)*

0.75 (1.002e−07)*

Omicron

0.1 (0.14)

0.48 (0.006)*

0.39 (0.017)*

0.16 (0.101)*

0.79 (5.89e−05)*

  1. We tested five predictors using a linear regression between a response variable (Re of each variant) and one variable or predictor (explanatory variables). The values in the table show the adjusted R-squared and (p-value). *: statistically significant. NA means that the variable was not recorded for all period of time that a particular variant circulated.